Literature DB >> 8656063

Okadaic acid inhibits the signal responsible for activation of the NADPH-oxidase in neutrophils stimulated with serum-opsonized yeast.

O Harbecke1, H Lundqvist, C Dahlgren.   

Abstract

The effects of the phosphatase inhibitor okadaic acid (OA) on human neutrophil phagocytic activity were investigated. The chemiluminescence response was found to be greatly reduced in OA-treated neutrophils during phagocytosis of serum opsonized yeast particles in comparison to control cells. However, the OA-treated neutrophils phagocytosed yeast particles to the same extent as control cells and the engulfment of the prey was accompanied by phagolysosomal formation in both OA-treated and nontreated cells. We thus found that the OA effect was selective in the sense that it inhibits the NADPH-oxidase activity in neutrophils phagocytosing yeast particles but not uptake of the prey or phagolysosomal formation. Based on the fact that the NADPH-oxidase activity induced by the chemoattractant formyl-methionyl-leucyl-phenylalanine was not reduced but elevated in OA-treated neutrophils, we conclude that the state of phosphorylation has no direct effect on the oxidase, but is of importance for the NADPH-oxidase activating signal(s) generated during phagocytosis of the yeast particles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656063     DOI: 10.1002/jlb.59.5.754

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  Coiling phagocytosis discriminates between different spirochetes and is enhanced by phorbol myristate acetate and granulocyte-macrophage colony-stimulating factor.

Authors:  M G Rittig; J C Jagoda; B Wilske; R Murgia; M Cinco; R Repp; G R Burmester; A Krause
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

2.  Modulation of the alveolar macrophage superoxide production by protein phosphorylation.

Authors:  H J Forman; H Zhou; E Gozal; M Torres
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.